Want to see HK:9960 full AI Analyst Report?
Kindstar Globalgene Technology, Inc. (9960) Ratios
Kindstar Globalgene Technology, Inc. Ratios
HK:9960's free cash flow for Q2 2026 was $17.49M. For the 2026 fiscal year, HK:9960's free cash flow was decreased by $-22.59M and operating cash flow was $55.61M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.81 | 2.63 | 3.64 | 3.19 | 5.68 |
| Quick Ratio | 2.74 | 2.57 | 3.58 | 3.12 | 5.57 |
| Cash Ratio | 0.53 | 0.45 | 1.98 | 0.79 | 3.97 |
| Solvency Ratio | 0.05 | -0.01 | 0.15 | 0.16 | -3.01 |
| Operating Cash Flow Ratio | 0.12 | -0.05 | -0.02 | 0.02 | 0.15 |
| Short-Term Operating Cash Flow Coverage | 0.53 | -0.15 | -0.10 | 0.12 | 0.00 |
| Net Current Asset Value | $ 1.10B | $ 1.30B | $ 1.93B | $ 1.88B | $ 2.11B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.11 | 0.05 | 0.05 | 0.01 |
| Debt-to-Equity Ratio | 0.16 | 0.14 | 0.07 | 0.07 | 0.01 |
| Debt-to-Capital Ratio | 0.14 | 0.13 | 0.06 | 0.07 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.02 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.38 | 1.36 | 1.28 | 1.32 | 1.17 |
| Debt Service Coverage Ratio | -0.45 | -0.41 | 0.74 | 0.79 | -402.13 |
| Interest Coverage Ratio | -7.45 | -4.09 | -5.29 | 28.03 | 10.83 |
| Debt to Market Cap | 0.38 | 0.34 | 0.10 | 0.09 | 0.00 |
| Interest Debt Per Share | 0.46 | 0.43 | 0.21 | 0.25 | 0.04 |
| Net Debt to EBITDA | -0.69 | -0.14 | -10.12 | -3.19 | 1.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.07% | 47.39% | 46.64% | 43.49% | 52.20% |
| EBIT Margin | -18.71% | -17.68% | 5.31% | 6.19% | -156.04% |
| EBITDA Margin | -7.41% | -12.64% | 13.07% | 10.87% | -149.86% |
| Operating Profit Margin | -11.89% | -4.88% | -4.39% | 5.09% | 4.04% |
| Pretax Profit Margin | -4.33% | -6.06% | 4.48% | 6.01% | -156.23% |
| Net Profit Margin | -6.29% | -5.89% | 4.27% | 5.44% | -156.28% |
| Continuous Operations Profit Margin | -5.91% | -6.54% | 3.77% | 5.59% | -156.26% |
| Net Income Per EBT | 145.45% | 97.15% | 95.30% | 90.57% | 100.03% |
| EBT Per EBIT | 36.38% | 124.04% | -102.00% | 118.09% | -3869.15% |
| Return on Assets (ROA) | -1.56% | -1.45% | 1.13% | 2.03% | -45.61% |
| Return on Equity (ROE) | -2.15% | -1.96% | 1.44% | 2.67% | -53.47% |
| Return on Capital Employed (ROCE) | -3.68% | -1.55% | -1.45% | 2.46% | 1.37% |
| Return on Invested Capital (ROIC) | -3.47% | -1.40% | -1.16% | 2.15% | 1.37% |
| Return on Tangible Assets | -1.68% | -1.46% | 1.14% | 2.05% | -46.01% |
| Earnings Yield | -5.88% | -5.21% | 2.83% | 3.65% | -62.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.36 | 1.81 | 1.67 | 2.18 | 2.74 |
| Payables Turnover | 4.38 | 2.74 | 2.33 | 2.62 | 3.30 |
| Inventory Turnover | 10.05 | 9.48 | 10.60 | 13.35 | 8.76 |
| Fixed Asset Turnover | 1.58 | 1.50 | 2.02 | 3.47 | 2.50 |
| Asset Turnover | 0.25 | 0.25 | 0.26 | 0.37 | 0.29 |
| Working Capital Turnover Ratio | 0.69 | 0.55 | 0.50 | 0.69 | 0.63 |
| Cash Conversion Cycle | 107.69 | 107.09 | 96.51 | 54.97 | 64.09 |
| Days of Sales Outstanding | 154.71 | 201.72 | 218.88 | 167.15 | 133.01 |
| Days of Inventory Outstanding | 36.30 | 38.52 | 34.44 | 27.34 | 41.69 |
| Days of Payables Outstanding | 83.33 | 133.15 | 156.81 | 139.52 | 110.61 |
| Operating Cycle | 191.01 | 240.24 | 253.32 | 194.49 | 174.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.09 | -0.05 | -0.02 | 0.03 | 0.14 |
| Free Cash Flow Per Share | 0.04 | -0.19 | -0.20 | -0.13 | -0.44 |
| Dividend Paid and CapEx Coverage Ratio | 1.30 | -0.28 | -0.08 | 0.17 | 0.19 |
| Capital Expenditure Coverage Ratio | 1.92 | -0.33 | -0.08 | 0.17 | 0.24 |
| Operating Cash Flow Coverage Ratio | 0.21 | -0.11 | -0.08 | 0.11 | 3.74 |
| Operating Cash Flow to Sales Ratio | 0.10 | -0.05 | -0.02 | 0.02 | 0.07 |
| Free Cash Flow Yield | 4.37% | -17.13% | -12.98% | -4.98% | -9.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.99 | -19.21 | 35.39 | 27.39 | -1.59 |
| Price-to-Sales (P/S) Ratio | 1.07 | 1.13 | 1.51 | 1.49 | 2.49 |
| Price-to-Book (P/B) Ratio | 0.37 | 0.38 | 0.51 | 0.73 | 0.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.89 | -5.84 | -7.70 | -20.09 | -10.50 |
| Price-to-Operating Cash Flow Ratio | 10.95 | -23.76 | -98.86 | 96.55 | 34.00 |
| Price-to-Earnings Growth (PEG) Ratio | -6.54 | 0.08 | -0.64 | -0.27 | 0.03 |
| Enterprise Value Multiple | -15.11 | -9.09 | 1.45 | 10.52 | -0.38 |
| Enterprise Value | 1.05B | 1.07B | 182.65M | 1.59B | 534.24M |
| EV to EBITDA | -15.11 | -9.09 | 1.45 | 10.52 | -0.38 |
| EV to Sales | 1.12 | 1.15 | 0.19 | 1.14 | 0.57 |
| EV to Free Cash Flow | 23.98 | -5.93 | -0.96 | -15.42 | -2.43 |
| EV to Operating Cash Flow | 11.47 | -24.15 | -12.36 | 74.10 | 7.85 |
| Tangible Book Value Per Share | 2.55 | 2.94 | 2.94 | 3.43 | 5.44 |
| Shareholders’ Equity Per Share | 2.75 | 2.94 | 2.96 | 3.45 | 5.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.37 | -0.08 | 0.16 | 0.07 | -0.00 |
| Revenue Per Share | 0.94 | 0.98 | 1.00 | 1.69 | 1.88 |
| Net Income Per Share | -0.06 | -0.06 | 0.04 | 0.09 | -2.93 |
| Tax Burden | 1.45 | 0.97 | 0.95 | 0.91 | 1.00 |
| Interest Burden | 0.23 | 0.34 | 0.84 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.10 | 0.11 | 0.11 | 0.07 | 0.10 |
| SG&A to Revenue | 0.46 | 0.41 | 0.11 | 0.06 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -2.26 | 0.79 | -0.36 | 0.26 | -0.05 |
Currency in CNY